Bicarbonate

Bicarbonate

SCHEMBL976297

C1=CC2CCC1C2.O=C(O)O

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.38
TDP1 Q9NUW8 2/20 0.38
APEX1 P27695 1/20 0.38
LMNA P02545 3/20 0.33
KDM4E B2RXH2 1/20 0.33
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
CA9 Q16790 1/20 0.31
CYP2D6 P10635 2/20 0.30
BLM P54132 2/20 0.30
ALOX15 P16050 1/20 0.30
TSHR P16473 1/20 0.30
CYP1A2 P05177 1/20 0.30
CYP2C19 P33261 1/20 0.30
RAB9A P51151 1/20 0.30
MEN1 O00255 1/20 0.30
THRB P10828 1/20 0.30
PMP22 Q01453 1/20 0.30
KMT2A Q03164 1/20 0.30
ABAT P80404 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bicarbonate SCHEMBL4270205 1.00 POLB (0.38) POLBTDP1APEX1LMNAKDM4E
Acetic Acid SCHEMBL539228 0.88 POLB (0.40) POLBTDP1APEX1LMNAKDM4E
SCHEMBL820392 0.88 KDM4E (0.33) POLBTDP1APEX1LMNAKDM4E
SCHEMBL2478423 0.84 POLB (0.32) POLBTDP1APEX1
SCHEMBL22982714 0.84 KDM4E (0.33) POLBTDP1APEX1LMNAKDM4E
SCHEMBL6065835 0.83
SCHEMBL4967707 0.83
SCHEMBL22129636 0.83
SCHEMBL11183068 0.83
Glycine SCHEMBL20659283 0.82 GLRA1 (0.48) POLBTDP1APEX1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111065966-B Improved fill material for reducing pattern collapse 霍尼韦尔国际公司 2023-12-05 CN claimed
CN-111133557-B Thermally removable filler material for anti-stiction applications 霍尼韦尔国际公司 2023-11-24 CN claimed
US-11396136-B2 3D printing support structures incorporating sacrificial materials XEROX CORPORATION (US) 2022-07-26 US claimed
CN-111133557-A Thermally removable fill material for anti-stiction applications 霍尼韦尔国际公司 2020-05-08 CN claimed
CN-111065966-A Improved fill material for reducing pattern collapse 霍尼韦尔国际公司 2020-04-24 CN claimed
US-20260033306-A1 PROTECTION OF SENSITIVE SURFACES IN SEMICONDUCTOR PROCESSING LAM RES CORP (US) 2026-01-29 US disclosed
US-20250132195-A1 METHODS AND FORMULATIONS FOR SACRIFICIAL BRACING, SURFACE PROTECTION, AND QUEUE-TIME MANAGEMENT USING STIMULUS RESPONSIVE POLYMERS LAM RESEARCH CORPORATION 2025-04-24 US disclosed
US-20240312778-A1 TEMPORARY CAPPING MATERIAL FOR OXIDE PREVENTION IN LOW TEMPERATURE DIRECT METAL-METAL BONDING LAM RESEARCH CORPORATION 2024-09-19 US disclosed
CN-118043941-A Methods and formulations for sacrificial support, surface protection and waiting time management using stimulus-responsive polymers 朗姆研究公司 2024-05-14 CN disclosed
WO-2024091977-A1 PROTECTION OF SENSITIVE SURFACES IN SEMICONDUCTOR PROCESSING LAM RESEARCH CORPORATION (US) 2024-05-02 WO disclosed
CN-111065966-B Improved fill material for reducing pattern collapse 霍尼韦尔国际公司 2023-12-05 CN disclosed
CN-111133557-B Thermally removable filler material for anti-stiction applications 霍尼韦尔国际公司 2023-11-24 CN disclosed
WO-2004036264-A2 POLYMERS, METHODS OF USE THEREOF, AND METHODS OF DECOMPOSITION THEREOF GEORGIA TECH RESEARCH CORPORATION (US) 2004-04-29 WO disclosed
US-6432891-B1 INTRODUCING INTO SOLID OR LIQUID, SOAP OR DETERGENT COMPOUND SELECTED FROM 1-CYCLOHEXYL-ETHYLBUTYRATE, 1-CYCLOHEXYL-ETHYLACETATE, 1-CYCLOHEXYL-ETHANOL, 4-ISOPROPYL-CYCLOHEXYLPROPIONATE BUSH BOAKE ALLEN INC., 2002-08-13 US disclosed
US-20020032131-A1 Malodor counteractant compositions and methods for preparing and using same BUSH BOAKE ALLEN INC. 2002-03-14 US disclosed
EP-1167507-A2 Malodor counteractant compositions and methods for preparing and using same Bush Boake Allen Inc. (US) 2002-01-02 EP disclosed
EP-0483667-B1 Cyclic imino derivatives, process for their preparation and drugs containing them THOMAE GMBH DR K (DE) 1998-02-04 EP disclosed
EP-0483667-A2 Cyclic imino derivatives, process for their preparation and drugs containing them Dr. Karl Thomae GmbH (DE) 1992-05-06 EP disclosed
EP-0251370-B1 Cyclohexane-, cyclohexene- and cyclohexadiene, bicyclo[2.2.1]heptane and bicyclo [2.2.1]heptenecarboxylic acid esters, and also perfume compositions and perfumed products which contain one or more of said compounds as perfume component NAARDEN INTERNATIONAL N.V. (NL) 1989-10-25 EP disclosed
EP-0251370-A1 Cyclohexane-, cyclohexene- and cyclohexadiene, bicyclo[2.2.1]heptane and bicyclo [2.2.1]heptenecarboxylic acid esters, and also perfume compositions and perfumed products which contain one or more of said compounds as perfume component NAARDEN INTERNATIONAL N.V. (NL) 1988-01-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260033306-A1 PROTECTION OF SENSITIVE SURFACES IN SEMICONDUCTOR PROCESSING CAPG, C9, CPSF1 POLB 1194/4885TDP1 1042/4885APEX1 155/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.